Showing results (1521-1530 of 1,692) with videos related to

Sort By:
Pageof 170
British Journal of Cancer|December 10, 2020
Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring ProjectGerard C Millen, Roland Arnold, Jean-Baptiste Cazier, et al.
BMJ Open|November 26, 2025
Neuropsychiatric research databases for people with intellectual disabilities and epilepsy (REFINE): a feasibility study protocolCrispin Musicha, Helen Neilens, Emily Stanyard, et al.
Nature Immunology|March 2, 2021
Effector and stem-like memory cell fates are imprinted in distinct lymph node niches directed by CXCR3 ligandsBrigette C Duckworth, Fanny Lafouresse, Verena C Wimmer, et al.
Plos One|May 11, 2012
The relationship between impulsive choice and impulsive action: a cross-species translational studyNienke Broos, Lianne Schmaal, Joost Wiskerke, et al.
Hereditary Cancer in Clinical Practice|November 25, 2011
Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening testsMarielle Ae Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|August 1, 2018
Mapping of novel salt tolerance QTL in an Excalibur × Kukri doubled haploid wheat populationMuhammad A Asif, Rhiannon K Schilling, Joanne Tilbrook, et al.
Neurotoxicology|August 15, 2017
Association of exposure to manganese and iron with striatal and thalamic GABA and other neurometabolites - Neuroimaging results from the WELDOX II studySwaantje Casjens, Urike Dydak, Shalmali Dharmadhikari, et al.
Plos One|July 14, 2010
Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: a clinical application of MALDI mass spectrometryJeroen J A van Kampen, Mariska L Reedijk, Peter C Burgers, et al.
British Journal of Cancer|April 20, 2023
The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer researchMatthew Fittall, Justin Liu, James Platt, et al.
The Lancet. Oncology|June 28, 2016
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trialLaurie H Sehn, Neil Chua, Jiri Mayer, et al.
Pageof 170